Literature DB >> 16803471

A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome.

D Faratian1, A Stillie, R M C Busby-Earle, V J Cowie, H Monaghan.   

Abstract

Uterine papillary serous carcinoma (UPSC) accounts for 10% of endometrial carcinomas but a higher proportion of deaths due to its aggressive nature and poor response to chemotherapy and radiotherapy. In order to add to the knowledge of UPSC in the literature and to review our local practices, we examined the pathology, medical records, and management of all cases of UPSC (67 patients) treated in South East Scotland over a 10-year period and also evaluated the prognostic significance of the percentage of UPSC in endometrial pipelle and hysterectomy specimens. Although only 63% of initial diagnostic biopsies were reported to contain UPSC, rereview of the cases revealed UPSC in 98.5% of the preoperative biopsies. The percentage of UPSC in the tumors did not affect the outcome. Stage, positive omentum, and treatment with external-beam +/- intracavitary radiotherapy were significantly correlated with overall survival and progression-free survival by univariate analysis, but only stage (P < 0.01) was correlated with outcome on multivariate analysis. Chemotherapy did not affect outcome. UPSC may be difficult to diagnose in preoperative biopsies, particularly when present as part of a mixed tumor. Even a small percentage of UPSC in a diagnostic biopsy or hysterectomy specimen is correlated with a poor prognosis. This study emphasizes the need of a cooperative, prospective study on this distinct uterine carcinoma.

Entities:  

Mesh:

Year:  2006        PMID: 16803471     DOI: 10.1111/j.1525-1438.2006.00576.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  7 in total

1.  Prognostic factors in stages II/III/IV and stages III/IV endometrioid and serous adenocarcinoma of the endometrium.

Authors:  P Mhawech-Fauceglia; R F Herrmann; J Kesterson; I Izevbaye; S Lele; K Odunsi
Journal:  Eur J Surg Oncol       Date:  2010-12       Impact factor: 4.424

Review 2.  Practical issues in the diagnosis of serous carcinoma of the endometrium.

Authors:  Sonia Gatius; Xavier Matias-Guiu
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

3.  Grade 1 Endometrioid Carcinoma With an Area of Serous Carcinoma Less than 5% Is More Aggressive than Stage IA Pure-type Grade 1 Endometrioid Carcinoma.

Authors:  Morikazu Miyamoto; Hitoshi Tsuda; Atsushi Sugiura; Tsunekazu Kita; Yoshitaka Kataoka; Kenji Ishii; Kazuya Kudo; Hiroko Matsuura; Hiroki Ishibashi; Hideki Iwahashi; Taira Hada; Rie Suzuki; Masashi Takano
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

4.  Insights into endometrial serous carcinogenesis and progression.

Authors:  Oluwole Fadare; Wenxin Zheng
Journal:  Int J Clin Exp Pathol       Date:  2009-01-10

5.  DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium.

Authors:  Manohar Pradhan; Ben Davidson; Vera Maria Abeler; Håvard Emil Danielsen; Claes Göran Tropé; Gunnar Balle Kristensen; Björn Åke Risberg
Journal:  Virchows Arch       Date:  2012-07-24       Impact factor: 4.064

6.  Malignant endometrial polyps: Report of two cases and review of literature with emphasize on recent advances.

Authors:  Ali Dastranj Tabrizi; Amir Vahedi; Hiedar Ali Esmaily
Journal:  J Res Med Sci       Date:  2011-04       Impact factor: 1.852

7.  The role of omentectomy in the surgical treatment of uterine serous carcinoma.

Authors:  Ming Chen; Peng Guo; Jifan Tan; Duo Liu; Shuzhong Yao
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-07-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.